Pliant Therapeutics
PLRX
PLRX
125 hedge funds and large institutions have $861M invested in Pliant Therapeutics in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
1.55% less ownership
Funds ownership: 93.23% → 91.68% (-1.6%)
7% less capital invested
Capital invested by funds: $925M → $861M (-$63.8M)
Holders
125
Holding in Top 10
9
Calls
$4.53M
Puts
$2.48M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$11.1M | |
| 3 | +$10.3M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.01M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.76M |
Top Sellers
| 1 | -$38.7M | |
| 2 | -$32.7M | |
| 3 | -$12.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.7M |
| 5 |
CA
CHI Advisors
New York
|
-$4.64M |